Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oliver Baker
Observed institution:
NEC (Germany)
OpenAlex ID:
A5105784796
Randomized phase I trial of adjuvant personalized cancer vaccine TG4050 in resected locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
2025
·
Christophe Le Tourneau
, Jean-Pierre Delord
, et al.
·
Journal of Clinical Oncology
·
10
PDF
Schroedinger's cash register: Physicists try to break economists' monopoly on financial theory
1999
·
Oliver Baker
·
Science News
·
4
The importance of being electric: Scientists aim to explain sprites
2000
·
Oliver Baker
·
Science News
·
3
A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial
2026
·
Christian Ottensmeier
, Jean-Pierre Delord
, et al.
·
Nature Communications
·
1
PDF
650 Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC)
2024
·
Christophe Le Tourneau
, Jean-Pierre Delord
, et al.
·
Regular and Young Investigator Award Abstracts
·
1
Abstract LB205: Feasibility and immunogenicity of adjuvant TG4050, a patient tailored cancer vaccine in head and neck and ovarian cancer
2023
·
Ana Lalanne
, Camille Jamet
, et al.
·
Cancer Research
·
1
Car‐emission standards improve rural air
1999
·
Oliver Baker
·
Science News
·
1
Focus: Blurring Clarifies Cell Movements
2003
·
Oliver Baker
Focus: Flexibility of Cell Membranes
2001
·
Oliver Baker
Chromosomes show plants' secret complexity
1999
·
Oliver Baker
·
Science News
Planetary potential surrounds most stars
1999
·
Oliver Baker
·
Science News
Detection scheme takes lesson from plants
1999
·
Oliver Baker
·
Science News
Mediæval accounts
1897
·
Oliver Baker
·
Notes and Queries
Leather drinking jacks
1895
·
Oliver Baker
·
Notes and Queries
Show more works
View as search
Works count:
14
Citation count:
21
H-index:
3
I10-index:
1
Year
Topic
Type
